Zydus receives tentative approval from USFDA for Tofacitinib tablets

Tofacitinib is used alone or with other medications to treat moderate to severe forms of rheumatoid arthritis, the company said in a BSE filing.

Zydus receives tentative approval from USFDA for Tofacitinib tablets
Drug firm Zydus Cadila Saturday said it has received tentative approval from the US health regulator to market Tofacitinib tablets, Photo: Pixabay
Written By: PTI
Updated: Sat, Apr 06, 2019
06:20 pm
New Delhi, PTI
RELATED NEWS
'Investment of Rs 3K-5K cr needed to create extra mfg facilities for COVID-19 vaccine' 'Investment of Rs 3K-5K cr needed to create extra mfg facilities for COVID-19 vaccine'
After Bharat Biotech, Zydus COVID-19 vaccine candidate gets nod from Centre for human trials After Bharat Biotech, Zydus COVID-19 vaccine candidate gets nod from Centre for human trials

Drug firm Zydus Cadila Saturday said it has received tentative approval from the US health regulator to market Tofacitinib tablets, used for the treatment of rheumatoid arthritis. Tofacitinib is used alone or with other medications to treat moderate to severe forms of rheumatoid arthritis, the company said in a BSE filing.

It helps to decrease pain, tenderness and swelling in the joints, it added.

It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.

The group now has 260 approvals and has so far filed over 350 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04, it added.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.